PANCREATIC SEROTONIN-PRODUCING NEUROENDOCRINE TUMOR

Clinical trials for PANCREATIC SEROTONIN-PRODUCING NEUROENDOCRINE TUMOR explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC SEROTONIN-PRODUCING NEUROENDOCRINE TUMOR trials appear

Sign up with your email to follow new studies for PANCREATIC SEROTONIN-PRODUCING NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for slowing advanced neuroendocrine tumors in major trial

Disease control Ongoing

This study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …

Matched conditions: PANCREATIC SEROTONIN-PRODUCING NEUROENDOCRINE TUMOR

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

PANCREATIC SEROTONIN-PRODUCING NEUROENDOCRINE TUMOR

Get alerted when new PANCREATIC SEROTONIN-PRODUCING NEUROENDOCRINE TUMOR trials appear

New hope for slowing advanced neuroendocrine tumors in major trial